Investor Ideas Potcasts, Cannabis News and Stocks on the Move; Episode 412 (OTC: $CSUI) (TSX: $FAF.TO) (CSE: $PILL.C) (CSE: $CURA.C) (TSX: $FIRE.TO) (OTCQX: $SPRWF) (CSE: $BLO.C)
Delta, Kelowna, BC, May 11, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Today’s podcast overview/transcript:
Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
In today’s podcast we will be looking at a few public company announcements.
Fire & Flower Holdings Corp. (TSX: FAF) (OTCQX: FFLWF), and its indirect wholly-owned subsidiary Hifyre™ Inc., today announced that the Spark Perks™ member program has achieved the milestone of 100,000 enrolled members across the Fire & Flower retail network.
Spark Perks offers its members access to services including Spark Fastlane™ "click-and-collect", curbside pickup and the Rapid Delivery™ home delivery service in jurisdictions where these programs are permitted. In addition, member benefits include exclusive discounts, member-only content and access to invite-only events.
On average, Spark Perks members spend 37% more per transaction than non-members and have purchased from Fire & Flower an average of 2.5 times in the past seven weeks. More than 50% of all Fire & Flower transactions are from Spark Perks members.
Sparks Perks continues to be a competitive advantage for Fire & Flower and since the onset of the COVID-19 public health crisis beginning in March 2020, more than 20,000 members have enrolled in the program.
"The Hifyre platform continues to be a competitive advantage for Fire & Flower in cannabis retailing. Engaged customers, repeat purchasing and higher than average transaction values are key in building our Retail Platform revenue stream," shared Trevor Fencott, Chief Executive Officer of Fire & Flower. "As consumer behaviours and preferences change towards increased digital engagement, Fire & Flower is well positioned to maximize market opportunities."
Canntab Therapeutics Limited (CSE:PILL)(OTCQB:CTABF), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, announced that Mr. Larry Latowsky, Special Advisor and future Executive Chairman of the Board of Directors of the Company (pending Health Canada approval), will present via webcast at the Canaccord Genuity 4th Annual Cannabis Conference, on Tuesday, May 12, 2020, at 9:20 a.m. (EST).
Mr. Latowsky's presentation is expected to discuss, among other things, the Company's top priorities, and strategic plans for the future.
"Many companies solicited my support and directorships, but I joined Canntab half a year ago because of my belief in Canntab's business model and its distinctive product offerings. Canntab's medical cannabis solutions, which will be critical to the adoption of cannabinoids by the medical community, place Canntab in a unique position to execute on significant opportunities that will generate sustainable value for all stakeholders," explains Larry Latowsky, Special Advisor and future Executive Chairman of the Board, pending Health Canada approval.
Mr. Latowsky brings decades of experience in the manufacturing, wholesale and distribution of pharmaceutical and nutraceutical products, having previously served as the President and CEO of Drug Trading Co., and Katz Group Canada, the parent company of, among others, Rexall Pharmaplus.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF), a leading vertically integrated cannabis operator in the United States, today announced an agreement with Mango Cannabis, the top medical cannabis dispensary in Oklahoma, to distribute Curaleaf's Select brand products. The brand is being distributed for the first time in Oklahoma at two Mango Cannabis dispensaries in Edmond and Tulsa.
Select, which was acquired by Curaleaf in February 2020, currently retails in Oregon, California, Nevada, Arizona, Colorado, Michigan, Maryland and Oklahoma. The brand is expanding across the country in the 17 states where Curaleaf operates. Select is initially launching in the Oklahoma market with its 1g Elite cartridge, the brand's most popular product that delivers an activated, broad-spectrum oil with a high THC level. The brand plans to offer Elite Live and other new products to Oklahoma medical patients in the near future.
"We are excited to launch our Select brand in Oklahoma through our partnership with Mango Cannabis, a trusted dispensary in the state," said Joe Bayern, President of Curaleaf. "As we focus on expanding the Select brand, entering Oklahoma allows us to reach an important and rapidly evolving medical marijuana market. We look forward to serving the health and well-being of medical patients in Oklahoma."
During the COVID-19 pandemic, cannabis businesses have been deemed an essential service in most states, including Oklahoma. Curaleaf remains committed to serving patients and customers with the products they rely on while implementing heightened safety and hygienic measures in all its facilities.
Whether consumers have enjoyed cannabis for years or just recently started their cannabis journey, 7ACRES is encouraging everyone to focus on what tastes delicious. Cannabis shares common flavours with many items people eat or drink every day, such as citrus and spice. By answering a few questions about your individual taste preferences at meetyourtastebuds.com, consumers will receive a personalized recommendation of a 7ACRES cultivar specifically selected for them.
"We are very excited to launch this interactive tool and help consumers distinguish their cannabis taste preferences. Taste plays a big part in a user's cannabis experience and, along with look and smell, can be a good differentiator of quality cannabis," said Nicole Sale, VP, Marketing & Communications. "During this difficult time of social distancing, consumers may not be able to engage budtenders as easily as they used to. Meetyourtastebuds.com can act as another source of information for those shopping from home."
Since legalization, many consumers have come to believe that THC is the primary trait to distinguish high quality from low quality cannabis strains. While THC can be important, so is the look, smell and taste of the flower. Strong, pungent sensory characteristics are key indicators of high end cannabis and should also be considered when purchasing. 7ACRES grows cannabis cultivars that respect the plant, offering unique aromatic notes and complex flavours to satisfy a wide variety of tastes. Cannabis is complex but finding a strain that excites consumers taste buds shouldn't be.
Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF), developer of marijuana breathalyzer devices for law enforcement and the workplace, reported that the Company has developed a new version of its THC Breath Analyzer (“THCBA”) and is preparing for additional testing with the device. Company engineers have updated several components in the THCBA and have changed the form factor for improved handling. Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of ∆9-tetrahydrocannabinol (“THC”) - the psychoactive component of marijuana that causes impairment. The THCBA incorporates microfluidic sensor technology for the detection of THC from breath. New pictures of the THCBA version 2.0 advanced prototype device are available on the Company’s website (www.cannabixtechnologies.com).
The THCBA has attractive features such as single-hand ergonomic design and single-stage direct breath capability. Testing to date, has shown from the time of sample intake, the device can provide results in under 5 minutes. The THCBA uses a disposable spit trap and provides easy to understand screen prompts for the positive and negative detection of THC in breath. Studies¹ have shown that breath is a better indicator of impairment than saliva, blood, or urine because THC is present in breath for a relatively short period of time (1-3 hours); whereas, it is excreted at detectable levels in other body fluids for many hours, days, or even weeks after smoking. This short time period of detection in breath aligns with the peak impairment window. The Company has been developing the THCBA with Dr. Mina Hoorfar at University of British Columbia (“UBC”) and has an exclusive technology license agreement with UBC.
In the immediate term, Cannabix scientists will be testing the THCBA 2.0 device with cannabis smokers in order to (a) have more cannabis user data to enhance the device’s machine learning database and (b) for continuous improvement purposes. It should be noted that testing with cannabis smokers under general COVID-19 restrictions in place has become more time-consuming as device sterilization and organizing multi-subject testing has become more onerous. In the THCBA 2.0 version, several components have been built using 3D printed technology for rapid prototyping and design flexibility, and engineers have begun experimenting with different materials and coatings that would be more advantageous in manufacturing processes. Since early March, our discussions with potential pilot/test-user groups were paused due to the COVID-19 pandemic, however the Company is pleased to report it is having renewed discussions with pilot-use cases and is actively navigating how such studies will be done with enhanced safety in mind.
Rav Mlait, CEO, stated, “Our team has been diligently pressing forward with development of our marijuana breathalyzer devices through the various constraints that the COVID-19 pandemic has presented to us and our suppliers. We have improved the design and form factor of the THCBA and look forward to collecting more user data.”
Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI), a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid monthly news and social media client on investorideas.com More disclaimer info:
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Contact Investorideas.com
800 665 0411
